Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-18 5:10 pm Unchanged | 2024-12-17 | 13D | Cara Therapeutics, Inc. CARA | Vifor (International) Ltd. | 616,398 13.500% | 0 (Unchanged) | Filing History |
| 2024-10-30 4:21 pm Unchanged | 2024-10-23 | 13D | Cara Therapeutics, Inc. CARA | Vifor (International) Ltd. | 616,398 13.500% | 0 (Unchanged) | Filing History |
| 2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 62,059 1.400% | -234,129 (-79.05%) | Filing History |
| 2024-02-13 6:50 pm Sale | 2023-12-31 | 13G | Cara Therapeutics, Inc. CARA | Bain Capital Life Sciences Opportunities III LP | 0 0.000% | -224,669 (Position Closed) | Filing History |
| 2024-02-13 5:01 pm Sale | 2023-12-29 | 13G | Cara Therapeutics, Inc. CARA | VANGUARD GROUP INC | 219,256 4.830% | -39,221 (-15.17%) | Filing History |
| 2024-01-29 3:26 pm Sale | 2023-12-31 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 296,188 6.500% | -12,309 (-3.99%) | Filing History |
| 2023-07-25 4:40 pm Unchanged | 2023-07-25 | 13G | Cara Therapeutics, Inc. CARA | Vifor (International) Ltd. | 616,398 13.700% | 0 (Unchanged) | Filing History |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 308,497 6.900% | -335,713 (-52.11%) | Filing History |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | Cara Therapeutics, Inc. CARA | VANGUARD GROUP INC | 258,477 5.770% | 5,747 (+2.27%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 644,211 14.400% | 0 (Unchanged) | Filing History |
| 2023-01-20 09:43 am Purchase | 2022-12-31 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 644,211 14.400% | 44,284 (+7.38%) | Filing History |
| 2022-11-18 4:16 pm Purchase | 2022-11-09 | 13G | Cara Therapeutics, Inc. CARA | Bain Capital Life Sciences Opportunities III LP | 224,669 5.000% | 224,669 (New Position) | Filing History |
| 2022-02-14 6:16 pm Sale | 2021-12-31 | 13G | Cara Therapeutics, Inc. CARA | FIRST MANHATTAN CO | 0 0.000% | -267,733 (Position Closed) | Filing History |
| 2022-02-14 11:35 am Sale | 2021-12-31 | 13G | Cara Therapeutics, Inc. CARA | RHO Ventures VI LP | 65 0.000% | -233,190 (-99.97%) | Filing History |
| 2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | Cara Therapeutics, Inc. CARA | VANGUARD GROUP INC | 252,730 5.670% | 252,730 (New Position) | Filing History |
| 2022-01-28 1:54 pm Sale | 2021-12-31 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 599,927 13.500% | -2,929 (-0.49%) | Filing History |
| 2021-10-21 4:15 pm Purchase | 2021-10-20 | 13G | Cara Therapeutics, Inc. CARA | Vifor (International) Ltd. | 616,398 13.900% | 273,533 (+79.78%) | Filing History |
| 2021-05-07 5:09 pm Purchase | 2021-04-30 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 602,856 14.500% | 300,168 (+99.17%) | Filing History |
| 2021-02-16 2:41 pm Purchase | 2020-12-31 | 13G | Cara Therapeutics, Inc. CARA | FIRST MANHATTAN CO | 267,733 6.450% | 267,733 (New Position) | Filing History |
| 2021-02-16 12:23 pm Sale | 2020-12-31 | 13G | Cara Therapeutics, Inc. CARA | PRICE T ROWE ASSOCIATES INC | 202,436 4.800% | -185,948 (-47.88%) | Filing History |